Patents by Inventor Mervyn Thompson

Mervyn Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190143773
    Abstract: An improved amphibious vehicle comprising: a drive train; a plurality of ground engaging wheels; a cooling system; a water propulsion system; and a hull which defines a passenger compartment, wherein the form/shape of the hull below the waterline is substantially defined by a plurality of buoyancy modules that are demountably mountable to the amphibious vehicle.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 16, 2019
    Applicant: SALAMANDER A.V. LIMITED
    Inventors: Ian George Mervyn Thompson, Robert Flint McDowell, Steven Barr, Andrew Colhoun
  • Patent number: 10207553
    Abstract: An improved amphibious vehicle comprising: a drive train; a plurality of ground engaging wheels; a cooling system; a water propulsion system; and a hull which defines a passenger compartment, wherein the form/shape of the hull below the waterline is substantially defined by a plurality of buoyancy modules that are demountably mountable to the amphibious vehicle.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: February 19, 2019
    Assignee: Salamander A.V. Limited
    Inventors: Ian George Mervyn Thompson, Robert Flint McDowell, Steven Barr, Andrew Colhoun
  • Publication number: 20170240013
    Abstract: An improved amphibious vehicle comprising: a drive train; a plurality of ground engaging wheels; a cooling system; a water propulsion system; and a hull which defines a passenger compartment, wherein the form/shape of the hull below the waterline is substantially defined by a plurality of buoyancy modules that are demountably mountable to the amphibious vehicle.
    Type: Application
    Filed: October 22, 2015
    Publication date: August 24, 2017
    Applicant: SALAMANDER A.V. LIMITED
    Inventors: Ian George Mervyn Thompson, Robert Flint McDowell, Steven Barr, Andrew Colhoun
  • Patent number: 9637974
    Abstract: A roller door system (100) particularly for opening and closing a doorway (120) defined in the wall of a lightweight structure (110) such as a marquee, hangar, field hospital, emergency shelter and the like. The door system comprises a rollable door (150) secured, in use, along one edge of the doorway (152); a roller (140) for rolling and unrolling the rollable door about the roller; an opening mechanism and a closing mechanism for controlling the deployment of the rollable door by translating the roller across the doorway; and reusable sealing means (135, 136, 155, 156) for sealing between the lateral margins of the rollable door and the doorway; characterized in that the rollable door comprises a plurality of collapsible hoses (165, 166) connected to a pressurized fluid power system (160, 161, 163) such that in use a positive pressure applied to the fluid power system causes the rollable door to unroll from the roller and controls the deployment of the rollable door.
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: May 2, 2017
    Assignee: The Secretary of State for Defence
    Inventor: Duncan Godfrey Mervyn Thompson
  • Publication number: 20160258212
    Abstract: A roller door system (100) particularly for opening and closing a doorway (120) defined in the wall of a lightweight structure (110) such as a marquee, hangar, field hospital, emergency shelter and the like. The door system comprises a rollable door (150) secured, in use, along one edge of the doorway (152); a roller (140) for rolling and unrolling the rollable door about the roller; an opening mechanism and a closing mechanism for controlling the deployment of the rollable door by translating the roller across the doorway; and reusable sealing means (135, 136, 155, 156) for sealing between the lateral margins of the rollable door and the doorway; characterised in that the rollable door comprises a plurality of collapsible hoses (165, 166) connected to a pressurised fluid power system (160, 161, 163) such that in use a positive pressure applied to the fluid power system causes the rollable door to unroll from the roller and controls the deployment of the rollable door.
    Type: Application
    Filed: October 23, 2014
    Publication date: September 8, 2016
    Applicant: THE SECRETARY OF STATE FOR DEFENCE
    Inventor: DUNCAN GODFREY MERVYN THOMPSON
  • Patent number: 8853218
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: October 7, 2014
    Assignee: Glaxo Group Limited
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Mervyn Thompson, Susan Marie Westaway, Samantha Louisa Brown
  • Patent number: 8536182
    Abstract: The present invention relates to novel benzylpiperazine derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: July 24, 2006
    Date of Patent: September 17, 2013
    Assignee: Glaxo Group Limited
    Inventors: Christopher Norbert Johnson, David Timothy Macpherson, Steven James Stanway, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Patent number: 8236953
    Abstract: The invention relates to compounds of formula (I): processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: August 7, 2012
    Assignee: Glaxo Group Limited
    Inventors: Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Patent number: 8236947
    Abstract: Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, and salts thereof, compositions containing these compounds and salts and processes for making and using the same.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: August 7, 2012
    Assignee: Glaxo Group Limited
    Inventors: Mahmood Ahmed, Christopher Norbert Johnson, Martin C Jones, Gregor James MacDonald, Stephen Frederick Moss, Mervyn Thompson, Charles Edward Wade, David R Witty
  • Patent number: 8063078
    Abstract: Certain compounds of formula (I), or a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein R1, R2, P, P?, n, p, q, r and s are as defined in the specification, a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: November 22, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Harshad Kantilal Rami, Mervyn Thompson
  • Publication number: 20110275815
    Abstract: The invention relates to compounds of formula (I): processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Application
    Filed: July 20, 2011
    Publication date: November 10, 2011
    Inventors: Jonathan Thomas SEAL, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Publication number: 20110237792
    Abstract: Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, and salts thereof, compositions containing these compounds and salts and processes for making and using the same.
    Type: Application
    Filed: June 3, 2011
    Publication date: September 29, 2011
    Inventors: Mahmood AHMED, Christopher Norbert Johnson, Martin C. Johnes, Gregor James MacDonald, Stephen Frederick Moss, Mervyn Thompson, Charles Edward Wade, David R. Witty
  • Patent number: 8012981
    Abstract: The invention relates to compounds of formula (I): processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: September 6, 2011
    Assignee: Glaxo Group Limited
    Inventors: Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Patent number: 7977337
    Abstract: Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, and salts thereof, compositions containing these compounds and salts and processes for making and using the same.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: July 12, 2011
    Assignee: Glaxo Group Limited
    Inventors: Mahmood Ahmed, Christopher Norbert Johnson, Martin C Jones, Gregor James MacDonald, Stephen Frederick Moss, Mervyn Thompson, Charles Edward Wade, David R Witty
  • Patent number: 7964597
    Abstract: Disclosed are motilin agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: June 21, 2011
    Assignee: Glaxo Group Limited
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Patent number: 7964602
    Abstract: The present invention relates to novel biaryl derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: June 21, 2011
    Assignee: Glaxo Group Limited
    Inventors: Gregor James MacDonald, Darren Jason Mitchell, Mervyn Thompson, Susan Marie Westaway
  • Publication number: 20110059979
    Abstract: Certain compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, P, P?, X, m and n are as defined in the specification, a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: August 12, 2004
    Publication date: March 10, 2011
    Applicant: GLAXO GROUP LIMITED
    Inventors: Craig Jamieson, David Drysdale Miller, Harshad Kantilal Rami, Mervyn Thompson
  • Publication number: 20100305107
    Abstract: Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, and salts thereof, compositions containing these compounds and salts and processes for making and using the same.
    Type: Application
    Filed: July 30, 2010
    Publication date: December 2, 2010
    Inventors: Mahmood AHMED, Christopher Norbert Johnson, Martin C. Jones, Gregor James MacDonald, Stephen Frederick Moss, Mervyn Thompson, Charles Edward Wade, David R. Witty
  • Publication number: 20100256364
    Abstract: Disclosed are motilin agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
    Type: Application
    Filed: November 26, 2008
    Publication date: October 7, 2010
    Inventors: Darren Jason Mitchell, Jonathan Thomas Seal, Geoffrey Stemp, Mervyn Thompson, Susan Marie Westaway
  • Patent number: 7799774
    Abstract: Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, and salts thereof, compositions containing these compounds and salts and processes for making and using the same.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: September 21, 2010
    Assignee: Glaxo Group Limited
    Inventors: Mahmood Ahmed, Christopher Norbert Johnson, Martin C Jones, Gregor James MacDonald, Stephen Frederick Moss, Mervyn Thompson, Charles Edward Wade, David R Witty